Logo
Inn J Pediatr

Image Credit:Inn J Pediatr

Investigating the Effect of Vitamin D Deficiency on Treatment Response in Children with Functional Constipation

Author(s):
Masoud OladianMasoud Oladian1, Zahra RazaviZahra RazaviZahra Razavi ORCID2, Hossein EsfahaniHossein EsfahaniHossein Esfahani ORCID3, Ali Reza SoltanianAli Reza SoltanianAli Reza Soltanian ORCID4, Hassan BazmamounHassan BazmamounHassan Bazmamoun ORCID5,*
1School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran
3Department of Pediatric Oncology, Hamadan University of Medical Sciences, Hamadan, Iran
4Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
5Department of Pediatric Gastroenterology, Hamadan University of Medical Sciences, Hamadan, Iran

Innovative Journal of Pediatrics:Vol. In Press, issue In Press; e159810
Published online:Jun 30, 2025
Article type:Research Article
Received:Jan 21, 2025
Accepted:May 31, 2025
How to Cite:Oladian M, Razavi Z, Esfahani H, Soltanian A R, Bazmamoun H. Investigating the Effect of Vitamin D Deficiency on Treatment Response in Children with Functional Constipation.Inn J Pediatr.2025;In Press(In Press):e159810.https://doi.org/10.5812/ijpediatr-159810.

Abstract

Background:

Constipation is a common childhood disease and is mostly functional. Previous studies have shown a relationship between constipation and vitamin D deficiency, but no study has examined the effect of vitamin D deficiency on the response to constipation treatment. The aim of this study is to investigate the effect of vitamin D deficiency on the response to constipation treatment in children with functional constipation.

Objectives:

This study aimed to evaluate the effect of vitamin D deficiency on the response to constipation treatment in children with functional constipation.

Methods:

In this cohort study, 62 children with functional constipation were divided into two equal groups: A group with vitamin D deficiency (study group) and a group without vitamin D deficiency (control group). Then, constipation treatment was performed for all patients, and the results were evaluated and compared in the two groups. The collected data were analyzed using SPSS software.

Results:

At the end of the second week of treatment, 74.2% of the patients in the control group responded to the treatment, which was statistically significantly higher than the study group (45.2%) (P = 0.038). Also, at the end of the second week, in the group with vitamin D deficiency, the response to the treatment in children with a vitamin D level of 10 to 29 ng/mL was statistically significantly better than in children with a vitamin D level of less than 10 ng/mL (P = 0.037).

Conclusions:

The results of this study showed that vitamin D deficiency has a negative effect on the response to the treatment of functional constipation in children.

1. Background

Vitamin D is an essential micronutrient obtained from the conversion of a provitamin in the skin in the presence of UVB rays from the sun to cholecalciferol, or by consuming food and supplements containing vitamin D through the digestive tract (1). Vitamin D is initially in an inactive form, and to convert into its active form, namely calcitriol, it requires two hydroxylations that are carried out in the liver and kidney (2-4). Calcitriol then binds to vitamin D receptors, which are found throughout the human body and through which it regulates several biological processes (3).

Serum levels of vitamin D in different regions depend on many factors such as season, latitude, cultural factors that lead to reduced exposure to UVB rays, gender, age, skin pigmentation, Body Mass Index, amount of vitamin D in foods, exercise, and physical activity (4). About 1 billion people worldwide are vitamin D deficient. Vitamin D deficiency is more common in Middle Eastern countries and also in people who have more skin melanin or use extensive skin coverage (5, 6).

Constipation is an intestinal dysfunction in which the patient experiences hard, dry, and infrequent stools along with pressure and pain. It is divided into two types: Organic and functional. Functional constipation is multifactorial, and no anatomical, medical, or medicinal cause can be found for it. Functional constipation is more common in children and accounts for about 25% of pediatric gastroenterology visits (7-9). According to the results of a meta-analysis, the prevalence of constipation ranges from 0.5% to 32.2%, with an overall prevalence of 9.5% (10).

Vitamin D has received more attention recently, especially its deficiency, which is associated with many systemic disorders. Apart from its effect on skeletal and extra-skeletal health (11), it has anti-inflammatory effects, modulates the immune system, and also affects gastrointestinal motility (12, 13). The relationship between vitamin D and chronic constipation is probably one of the least studied topics.

2. Objectives

This study aimed to investigate the effect of vitamin D deficiency on the response to constipation treatment in children with functional constipation.

3. Methods

In this cohort study, 62 children aged 1 to 18 years with functional constipation, referred to Ekbatan Hospital in Hamedan, Iran (during 2024), were studied. First, a blood sample from the basilic vein was obtained from all patients, and after centrifugation, the serum level of D(OH)25 was measured by the Enzyme-Linked Fluorescent Assay method (Biomerieux company kit made in France was used).

Based on vitamin D levels, patients were divided into two equal groups: Patients with vitamin D deficiency (study group) and patients without vitamin D deficiency (control group). Then, patients in both groups underwent constipation treatment, and the results of the treatment were evaluated and compared at the end of the second week, the first month, and the second month of treatment.

A vitamin D level equal to or higher than 30 ng/mL was considered normal. Treatment of functional constipation included dietary changes and consumption of Pidrolox powder without electrolytes (manufactured by Sepidage Company) with a dose of 0.7 g/kg twice a day (maximum dose 13.8 - 40 g per day). For patients with fecal impaction, a bisacodyl suppository of 5 mg per day was used for 3 to 5 days.

Diagnosis of fecal impaction was conducted through abdominal examination, digital rectal examination, and, if necessary, simple abdominal radiography. Inclusion criteria included age 1 to 18 years, functional constipation diagnosed by a pediatric gastroenterologist based on the Rome IV criteria (14), and informed consent of the patient or parents to participate in the study. Patients with organic constipation and those taking medications that could alter bowel movements were excluded from the study.

In this study, the descriptive statistics section utilized mean and standard deviation to describe and report quantitative variables, while frequency and percentage were used for qualitative variables. In the analytical statistics section, demographic and basic characteristics were first compared between the two groups. An independent t-test was used to examine quantitative variables in the two groups. A chi-square test was used to compare qualitative variables in the two groups. To check the status of the response to the treatment at the investigated times, the frequency of recovery in the two groups was compared using the chi-square test.

Data analysis was conducted using SPSS version 20 software, and the significance level was considered less than 0.05 in all cases.

The Ethics Committee of the Hamadan University of Medical Sciences approved this study with the ethics code, the Deputy of Research and Technology IR.UMSHA.REC.1402.060.

4. Results

Of the 31 children with vitamin D deficiency, 10 (32.3%) were male, and of the 31 children without vitamin D deficiency, 12 (38.7%) were male (P > 0.05). There was no significant difference between the two groups in terms of demographic information (Table 1).

Table 1.Demographic Characteristics and Serum Vitamin D Levels of the Patients a
VariablesPatients with Vitamin D Deficiency (N = 31)Patients with Normal Vitamin D (N = 31)P-Value
Age (y)6.1 ± 4.25.4 ± 3.5> 0.05
Weight (kg)16.2 ± 5.814.7 ± 5.6> 0.05
Height (cm)110.7 ± 4.2111.3 ± 4.3> 0.05
Vitamin D level (ng/ML )15.96 ± 8.6968.31 ± 17.11-

Demographic Characteristics and Serum Vitamin D Levels of the Patients a

At the end of the second week of treatment, 45.2% of patients in the study group responded to constipation treatment, which was statistically significantly lower than the control group (74.2%) (P = 0.038). Additionally, at the end of the second week, the response to the treatment of constipation in patients with vitamin D deficiency with a serum level of 10 to 29 ng/mL (71.4%) was significantly better than in patients with vitamin D deficiency with a serum level of less than 10 ng/mL (20%) (P = 0.037).

At the end of the first month of treatment, 71% of patients in the study group and 90.3% of patients in the control group responded to constipation treatment, but this difference was not statistically significant (P = 0.108). Furthermore, at the end of the first month of treatment, in the group with vitamin D deficiency, 95.2% of patients with vitamin D levels between 10 and 29 ng/mL and 70% of patients with vitamin D levels less than 10 ng/mL responded to the treatment, with no statistically significant difference (P = 0.425). At the end of the second month of treatment, all patients in both groups responded to the treatment of constipation, and no significant difference was seen between the two groups.

5. Discussion

The results of this study showed that the response to constipation treatment at the end of the second week was significantly better in patients who were not vitamin D deficient. Additionally, the response to treatment was significantly better in patients whose serum vitamin D levels were 10 to 29 ng/mL compared to those whose serum vitamin D levels were less than 10 ng/mL. The relationship between vitamin D deficiency and intestinal motility disorders is not yet fully understood. Some believe that delayed small intestinal transit time may negatively affect the microbiota of the small intestine (15), or conversely, changes in the microbiota may initially affect the mucosal barrier and subsequently reduce intestinal motility due to microbial-derived metabolites (16).

Other studies have shown that vitamin D deficiency can increase susceptibility to gastrointestinal infections (17) and cause disruption of immune homeostasis (16, 18). The presence of vitamin D receptors on the surface of intestinal epithelial cells, lymphocytes, and macrophages suggests a possible relationship between vitamin D deficiency and the composition of the intestinal microbiota, which ultimately leads to the onset of several chronic diseases in the body (16, 19, 20).

Finally, some researchers hypothesize that intestinal motility disorder may be the initial trigger of an underlying autoimmune process in a specific genetic background, which manifests itself due to chronic vitamin D deficiency. This can cause metabolic/immunological damage to the epithelial and neuromuscular structures of the intestine. The damages that occur include increased intestinal permeability and bacterial translocation, with the degree and spread influenced by the severity of vitamin D deficiency (21-23). Few studies have been conducted to date on the prevalence of vitamin D deficiency in functional constipation, and no study was found in the literature on the effect of vitamin D deficiency on the treatment of constipation to compare with the present study.

A study by Panarese et al. on the prevalence of vitamin D deficiency in adult patients with chronic constipation showed that vitamin D levels were significantly lower in the functional constipation group than in the control group. Additionally, the prevalence of constipation symptoms was related to the severity of vitamin D deficiency (21). In another study by Metwally, conducted on 55 children with chronic functional constipation, vitamin D deficiency was significantly more common in constipated patients than in the control group (24).

Additionally, the results of Parker-Autry et al.'s study on women with fecal incontinence (31 cases) compared to healthy women (81 cases) showed that women with fecal incontinence had significantly lower vitamin D levels than the control group (25). The study conducted by El Amrousy et al. demonstrated that adolescent patients with IBS who received vitamin D supplementation experienced a significant improvement in clinical symptoms compared to the placebo group. Vitamin D supplementation in IBS patients can improve their symptoms and quality of life by reducing anxiety, stress, and depression (26).

5.1. Conclusions

The results of the present study showed that vitamin D deficiency has a negative effect on the response to constipation treatment in children with functional constipation. Therefore, it is advisable to check vitamin D levels in these patients and treat them if they are deficient.

Acknowledgments

Footnotes

References

  • 1.
    Carmeliet G, Dermauw V, Bouillon R. Vitamin D signaling in calcium and bone homeostasis: a delicate balance. Best Pract Res Clin Endocrinol Metab. 2015;29(4):621-31. [PubMed ID: 26303088]. https://doi.org/10.1016/j.beem.2015.06.001.
  • 2.
    Muntingh GL. Vitamin D – The Vitamin Hormone. South African Fam Practice. 2016;58(3). https://doi.org/10.4102/safp.v58i3.4459.
  • 3.
    Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-29. [PubMed ID: 24529992]. [PubMed Central ID: PMC3968073]. https://doi.org/10.1016/j.chembiol.2013.12.016.
  • 4.
    Nguyen T. Vitamin D and Vitamin D Analogs. J Nurse Practitioners. 2016;12(3):208-9. https://doi.org/10.1016/j.nurpra.2015.12.020.
  • 5.
    Nair R, Maseeh A. Vitamin D: The “sunshine” vitamin. J Pharmacol Pharmacotherapeutics. 2012;3(2):118-26.
  • 6.
    Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144 Pt A:138-45. [PubMed ID: 24239505]. [PubMed Central ID: PMC4018438]. https://doi.org/10.1016/j.jsbmb.2013.11.003.
  • 7.
    Di Lorenzo C. Pediatric anorectal disorders. Gastroenterol Clin North Am. 2001;30(1):269-87. ix. [PubMed ID: 11394035]. https://doi.org/10.1016/s0889-8553(05)70178-3.
  • 8.
    Rajindrajith S, Devanarayana NM. Constipation in children: novel insight into epidemiology, pathophysiology and management. J Neurogastroenterol Motil. 2011;17(1):35-47. [PubMed ID: 21369490]. [PubMed Central ID: PMC3042216]. https://doi.org/10.5056/jnm.2011.17.1.35.
  • 9.
    Van den Berg MM, Benninga M, Di Lorenzo C. Epidemiology of childhood constipation: A systematic review. Am J Gastroenterol. 2006;101:2401-9. [PubMed ID: 17032205]. https://doi.org/10.1111/j.1572-0241.2006.00771.x.
  • 10.
    Koppen IJN, Vriesman MH, Saps M, Rajindrajith S, Shi X, van Etten-Jamaludin FS, et al. Prevalence of Functional Defecation Disorders in Children: A Systematic Review and Meta-Analysis. J Pediatr. 2018;198:121-130 e6. [PubMed ID: 29656863]. https://doi.org/10.1016/j.jpeds.2018.02.029.
  • 11.
    Khayyat Y, Attar S. Vitamin D Deficiency in Patients with Irritable Bowel Syndrome: Does it Exist? Oman Med J. 2015;30(2):115-8. [PubMed ID: 25960837]. [PubMed Central ID: PMC4412886]. https://doi.org/10.5001/omj.2015.25.
  • 12.
    Akimbekov NS, Digel I, Sherelkhan DK, Lutfor AB, Razzaque MS. Vitamin D and the host-gut microbiome: a brief overview. Acta Histochem Cytochem. 2020;53:33-42. [PubMed ID: 32624628]. [PubMed Central ID: PMC7322162]. https://doi.org/10.1267/ahc.20011.
  • 13.
    Kedar A, Vedanarayanan V, Nikitina Y, Griswold M, Abell T. Role of Vitamin D on Gastric Motility in Patients with Gastroparesis from Inflammatory Enteric Neuropathy (P05.198). Neurology. 2012;78(Meeting Abstracts 1):P05.198. https://doi.org/10.1212/WNL.78.1_MeetingAbstracts.P05.198.
  • 14.
    Zeevenhooven J, Koppen IJ, Benninga MA. The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers. Pediatr Gastroenterol Hepatol Nutr. 2017;20(1):1-13. [PubMed ID: 28401050]. [PubMed Central ID: PMC5385301]. https://doi.org/10.5223/pghn.2017.20.1.1.
  • 15.
    Vaes AMM, Brouwer-Brolsma EM, van der Zwaluw NL, van Wijngaarden JP, Berendsen AAM, van Schoor N, et al. Food sources of vitamin D and their association with 25-hydroxyvitamin D status in Dutch older adults. J Steroid Biochem Mol Biol. 2017;173:228-34. [PubMed ID: 27777183]. https://doi.org/10.1016/j.jsbmb.2016.10.004.
  • 16.
    Clark A, Mach N. Role of Vitamin D in the Hygiene Hypothesis: The Interplay between Vitamin D, Vitamin D Receptors, Gut Microbiota, and Immune Response. Front Immunol. 2016;7:627. [PubMed ID: 28066436]. [PubMed Central ID: PMC5179549]. https://doi.org/10.3389/fimmu.2016.00627.
  • 17.
    Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5(12):986-1004. [PubMed ID: 29102433]. https://doi.org/10.1016/S2213-8587(17)30357-1.
  • 18.
    Ge X, Zhao W, Ding C, Tian H, Xu L, Wang H, et al. Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility. Sci Rep. 2017;7(1):441. [PubMed ID: 28348415]. [PubMed Central ID: PMC5428802]. https://doi.org/10.1038/s41598-017-00612-y.
  • 19.
    He L, Liu T, Shi Y, Tian F, Hu H, Deb DK, et al. Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis. Endocrinology. 2018;159(2):967-79. [PubMed ID: 29228157]. [PubMed Central ID: PMC5788002]. https://doi.org/10.1210/en.2017-00748.
  • 20.
    Shahini E, Iannone A, Romagno D, Armandi A, Carparelli S, Principi M, et al. Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy. Aliment Pharmacol Ther. 2018;48(10):1138-45. [PubMed ID: 30375693]. https://doi.org/10.1111/apt.14999.
  • 21.
    Panarese A, Pesce F, Porcelli P, Riezzo G, Iacovazzi PA, Leone CM, et al. Chronic functional constipation is strongly linked to vitamin D deficiency. World J Gastroenterol. 2019;25(14):1729-40. [PubMed ID: 31011257]. [PubMed Central ID: PMC6465937]. https://doi.org/10.3748/wjg.v25.i14.1729.
  • 22.
    De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil. 2004;16(5):515-31. [PubMed ID: 15500508]. https://doi.org/10.1111/j.1365-2982.2004.00538.x.
  • 23.
    Spear ET, Holt EA, Joyce EJ, Haag MM, Mawe SM, Hennig GW, et al. Altered gastrointestinal motility involving autoantibodies in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neurogastroenterol Motil. 2018;30(9). e13349. [PubMed ID: 29644797]. [PubMed Central ID: PMC6153444]. https://doi.org/10.1111/nmo.13349.
  • 24.
    Metwally RH. Screening of vitamin D deficiency in children with chronic functional constipation. Gastroenterol Rev/Przegląd Gastroenterologiczny. 2024;19(1).
  • 25.
    Parker-Autry CY, Gleason JL, Griffin RL, Markland AD, Richter HE. Vitamin D deficiency is associated with increased fecal incontinence symptoms. Int Urogynecol J. 2014;25(11):1483-9. [PubMed ID: 24807423]. [PubMed Central ID: PMC4192075]. https://doi.org/10.1007/s00192-014-2389-7.
  • 26.
    El Amrousy D, Hassan S, El Ashry H, Yousef M, Hodeib H. Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful? A randomized controlled trial. Saudi J Gastroenterol. 2018;24(2):109-14. [PubMed ID: 29637918]. [PubMed Central ID: PMC5900470]. https://doi.org/10.4103/sjg.SJG_438_17.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles